mecamylamine has been researched along with Allergy, Drug in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glover, ED | 1 |
| Laflin, MT | 1 |
| Schuh, KJ | 1 |
| Schuh, LM | 1 |
| Nides, M | 1 |
| Christen, AG | 1 |
| Glover, PN | 1 |
| Strnad, JV | 1 |
1 trial available for mecamylamine and Allergy, Drug
| Article | Year |
|---|---|
A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Drug Administration Routes; Drug Hypers | 2007 |